|Bid||105.00 x 900|
|Ask||125.00 x 1200|
|Day's range||110.46 - 112.50|
|52-week range||83.14 - 143.14|
|Beta (5Y monthly)||1.07|
|PE ratio (TTM)||44.28|
|Earnings date||08 Feb 2023|
|Forward dividend & yield||3.24 (2.93%)|
|Ex-dividend date||27 Dec 2022|
|1y target est||123.32|
NEW YORK, January 24, 2023--IFF (NYSE: IFF) today announced the appointment of accomplished consumer products industry executive Dawn Willoughby to the Company’s Board of Directors as an independent director, effective Feb. 1, 2023. Willoughby, who most recently served as executive vice president and chief operating officer of The Clorox Company, brings an impressive track record of driving sustainable, profitable growth with a focus on innovation and sustainability for global consumer businesse
NEW YORK, January 23, 2023--IFF (NYSE:IFF) today announced that it will release its fourth quarter & full year 2022 earnings results following the market close on Wednesday, Feb 8, 2023. The management team will host a live webcast on Thursday, Feb. 9, 2023 at 9:00 a.m. ET to discuss results and outlook with the investor community.
Danisco Animal Nutrition & Health, a business unit of IFF, today announced it has received approval from the Canadian Food Inspection Agency (CFIA) for Enviva® PRO and Syncra® SWI. The incorporation of the newly approved feed solutions in poultry and swine diets will allow producers in Canada to benefit from more consistent animal performance throughout the year.